Chalcone has a structure of 1,3-diaryl-2-propen-1-one in which the two aromatic rings are joined by a three-carbon α,β-unsaturated carbonyl system, representing a class of flavonoids that occur naturally in fruits and vegetables. Chalcones are also metabolic precursors of some flavonoids and isoflavonoids (1) . Chalcones are promising lead antitumor/chemopreventive drugs due to three different activities: antioxidant, cytotoxic, and apoptosis induction (2) . Several studies with murine xenograft models have shown that administration of chalcones significantly reduced the tumor volume by inducing apoptosis (3) (4) (5) (6) (7) (8) (9) (10) . The tumor specificity of chalcones has been reported in comparing sensitivity of hepatocarcinoma HepG2 cells to normal liver AML12 cells (11) ; osterosarcoma to bone marrow and smallintestinal epithelial cells (12) ; murine acute lymphoblastic leukemia cells L-1210 to normal human lymphocytes (13) ; and human prostate cancer cells PC3 and DU145 to normal human prostate epithelial cells (14) . Although chalcones have been reported to induce apoptosis of human oral carcinoma cell line (HSC-3) (15) and cultured primary and metastatic oral cancer cell lines (16) , the tumor specificity against these has not been investigated as far as we are aware of.
In order to find new types of anticancer drugs active against human oral cancer, we first investigated the tumor specificity of 15 chalcone derivatives (Figure 1 ), using four human oral squamous cell carcinoma (OSCC) cell lines (Ca9-22, HSC-2, HSC-3, HSC-4) and three human normal oral cells (gingival fibroblast, HGF; periodontal ligament fibroblast, HPLF; pulp cells, HPC) as target cells, and then the apoptosis-inducing activity of the most active compound. The cytotoxicity data were used to perform the quantitative structure-activity relationship (QSAR) analysis. Since very few articles have been published on the antiviral activity of chalcones, we also investigated whether any of these compounds has any anti-human immunodeficiency virus (HIV) activity.
Materials and Methods

Materials.
The following chemicals and reagents were obtained from the indicated companies: Dulbecco's modified Eagle's medium (DMEM), from GIBCO BRL, Grand Island, NY, USA; fetal bovine serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), doxorubicin, azidothymidine, 2',3'-dideoxycytidine from Sigma-Aldrich Inc., St. Louis, MO, USA; dimethyl sulfoxide (DMSO), dextran sulfate (molecular mass, 5 kDa) from Wako Pure Chem. Ind., Osaka, Japan; methotrexate from Nacalai Tesque, Inc., Kyoto, Japan; curdlan sulfate (molecular mass: 79 kDa) from Ajinomoto Co. Ltd., Tokyo, Japan. Culture plastic dishes and plates (96-well) were purchased from Becton Dickinson (Franklin Lakes, NJ, USA). Figure 1 ) were synthesized by base-catalyzed condensation of the appropriate acetophenone with selected benzaldehyde derivatives according to previous methods (17) . All compounds were dissolved in DMSO at 40 mM and stored at -20˚C before use.
Synthesis of test compounds.
Cell culture. Human normal oral mesenchymal cells (HGF, HPLF, HPC), established from the first premolar tooth extracted from the lower jaw of a 12-year-old girl (18) , and human OSCC cell lines [Ca9-22 (derived from gingival tissue); HSC-2, HSC-3, HSC-4 (derived from tongue)], purchased from Riken Cell Bank (Tsukuba, Japan), were cultured at 37˚C in DMEM supplemented with 10% heat-inactivated FBS, 100 units/ml, penicillin G and 100 μg/ml streptomycin sulfate under a humidified 5% CO 2 atmosphere. HGF, HPLF and HPC cells at 10-18 population doubling levels were used in the present study.
Assay for cytotoxic activity. Cells were inoculated at 2.5×10 3 cells/0.1 ml in a 96-microwell plate (Becton Dickinson Labware, Franklin Lakes, NJ, USA).After 48 h, the medium was replaced with 0.1 ml of fresh medium containing different concentrations of single test compounds. Cells were incubated further for 48 h and the relative viable cell number was then determined by the MTT method (19) . The relative viable cell number was determined by the absorbance of the cell lysate at 562 nm, using a microplate reader (Sunrise Rainbow RC-R; TECAN, Männedorf, Switzerland). Control cells were treated with the same amounts of DMSO and the cell damage induced by DMSO was subtracted from that induced by test agents. The concentration of compound that reduced the viable cell number by 50% (CC 50 ) was determined from the doseresponse curve and the mean value of CC 50 for each cell type was calculated from duplicate assays. Table I ]. Since both Ca9-22 and HGF cells were derived from the gingival tissue (20) , the relative sensitivity of these cells was also compared [(C/A) in Table I ]. We have confirmed that the TS value thus determined reflects the antitumor potential of test samples, although normal and tumor cells are derived from different tissues (mesenchymal or epithelial tissues, respectively) (21). We did not use human normal oral keratinocytes as controls, since doxorubin and 5-fluorouracil showed potent cytotoxicity against these epithelial cells by an as yet unidentified mechanism (19, 22, 23) . Table II) .
Calculation of tumor-selectivity index (TS). TS was calculated using
Calculation of potency-selectivity expression (PSE)
.
Estimation of CC 50 values.
Since the CC 50 values had a distribution pattern close to a logarithmic normal distribution, we used the pCC 50 (i.e., the −log CC 50 ) for the comparison of the cytotoxicity between the compounds. The mean pCC 50 values for normal cells and tumor cell lines were defined as N and T, respectively (19) . Western blot analysis. The cells were washed with PBS and processed for western blot analysis, as described previously (29) . Antibodies against cleaved caspase-3 (Cell Signaling Technology Inc., Beverly, MP, USA), poly(ADP-ribose) polymerase (PARP) (Cell Signaling Technology Inc.) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Trevigen, Gaithersburg, MD, USA) were used as primary antibodies. As secondary antibodies, we used α-rabbit IgG (DAKO Japan) antibodies which were conjugated with horseradish peroxidase. (Table I) . Among them, compounds 10, 12 and 15 had higher TS (5.7-8.6) than other compounds, comparable to that of anticancer drugs, doxorubicin (5.5). When tumor selectivity was calculated using cells both derived from gingival tissue (Ca9-22 vs. HGF), 14 compounds 1-13 and 15 had much higher TS (2.1-5.6), exceeding that of doxorubicin (1.9). Compound 15 had the highest TS values in both cases. In order to identify compounds which have both good potency and are selectively toxic to neoplasms, the PSE values for the compounds were calculated. When all three normal cells (HGF, HPLF and HPC) and all four OSCC cell lines (Ca9-22, HSC-2, HSC-3 and HSC-4) were used, doxorubicin had the highest PSE value (>6,865), followed by methotrexate > compound 15 > compounds 1-14 (Table  I) . When HGF and Ca9-22 cells (both derived from gingival tissues) were used, the same pattern was found. Compound 15 had the highest PSE value among the 15 chalcones, approaching that of methotrexate. Western blot analysis demonstrated that compound 15 stimulated the cleavage of PARP and caspase-3, suggesting the induction of apoptosis (Figure 2 ).
Assay for anti-HIV activity. HTLV-I-carrying human T-cell line MT-
Anti-HIV activity of chalcones.
In contrast to popular anti-HIV agents (dextran sulfate, curdlan sulfate, azidothymidine, 2',3'-dideoxycytidine) (SI=300-5,805), none of the chalcones protected cells from the cytopathic effect of HIV infection (SI<1) ( Table II) . Based on these data, the subsequent QSAR analysis was focused on the cytotoxicity of chalcones.
Computational analysis. We next performed the QSAR analysis of chalcone derivatives in regards to their cytotoxicity against tumor cells and normal cells. Among a total of 3,092 descriptors (295 MOE and 2797 Dragon descriptors), 16 (Figure 4) .
Tumor specificity of chalcones was correlated with R6p (polarizability) (r 2 =0.601, p=0.0007), R5v+(van der Waal's volume) (r2=0.598, p=0.0007), L3m (mass) (r 2 =0.581, p=0.0009), VE2_H2 (average coefficient of the last eigenvector from reciprocal squared distance matrix) (r 2 =0.575, p=0.0010), L3s (atomic ionization state) (r 2 =0.565, p=0.0012) and HATS6p (polarizability) (r 2 =0.563, p=0.0013) ( Figure 5) .
Discussion
The present study demonstrated that 15 chalcones showed relatively higher cytotoxicity against four OSCC cell lines compared to that against human normal oral mesenchymal oral cells; among them, compound 15 had the highest TS and PSE values, although this is not a new compound. It should be noted that the TS value of 15 was comparable with that of doxorubicin, and the PSE value of 15 was comparable with that of methotrexate (Table I) . It is ideal to use human epithelial cells as control normal cells in comparison with OSCC cell lines. However, we recently found that doxorubicin induced apoptosis in human oral keratinocytes (i.e. loss of cell surface microvilli, chromatin condensation, nuclear fragmentation, caspase-3 activation) at the concentration that affected the viability of OSCC cell lines (31) . Until the mechanism of keratinocyte toxicity is clarified and a preventive method is explored, the use of human oral mesenchymal cells rather than normal epithelial cells may be the only choice for us to use in comparison with tumor cells. We calculated the possible contribution of substituted groups to the expression of cytotoxicity against OSCC cell lines and normal oral mesenchymal cells and tumor-specificity (Table  III) . Most of the substituents listed did not affect these activities (p=0.1067-0.9465) except for hydroxyl group (p=0.0167) or oxygen (p=0.0248) at R5 in determining cytotoxicity against normal cells. These data, suggest that tumor specificity of chalcones was rather correlated with molecular structure and polarization ( Figure 5 ). We also found that correlated parameters differed between tumor cells and normal cells. For example, R6P (which represents polarizability) is correlated with cytotoxicity against tumor cells ( Figure 3 ) and with tumor selectivity (Figure 5 ), but not so with cytotoxicity against normal cells (Figure 4 ). These data indicate that an increase of polarizability of chalcones may increase their antitumor potential.
The present study demonstrated that 15 chalcones did not have any anti-HIV activity. This finding is not contradictory with recent reports that chalcones exert anti-HIV activity partially or in a very narrow range of concentrations (32, 33) .
In conclusion, compound 15 is a potential lead compound for synthesizing more potent compounds targeted to OSCC cells.
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